Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 32192573

Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2020 Apr
First author
Davis KL

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2020 Apr;21(4):474-476. doi: 10.1016/S1470-2045(20)30086-3.
    note
    Source null
    related pmid
    32192574
    relationship
    Comment in

Authors and identifiers

  1. name
    Davis KL
    type
    Author
  2. name
    Fox E
    type
    Author
  3. name
    Merchant MS
    type
    Author
  4. name
    Reid JM
    type
    Author
  5. name
    Kudgus RA
    type
    Author
  6. name
    Liu X
    type
    Author
  7. name
    Minard CG
    type
    Author
  8. name
    Voss S
    type
    Author
  9. name
    Berg SL
    type
    Author
  10. name
    Weigel BJ
    type
    Author
  11. name
    Mackall CL
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Davis KL
    type
    Author
  2. name
    Fox E
    type
    Author
  3. name
    Merchant MS
    type
    Author
  4. name
    Reid JM
    type
    Author
  5. name
    Kudgus RA
    type
    Author
  6. name
    Liu X
    type
    Author
  7. name
    Minard CG
    type
    Author
  8. name
    Voss S
    type
    Author
  9. name
    Berg SL
    type
    Author
  10. name
    Weigel BJ
    type
    Author
  11. name
    Mackall CL
    type
    Author
bibliography ids
  1. nci-bib-a82f71371b13ff628c3392bd
book metadata
content sha256
0aae694b2fd692ed9665c7526b75eab8519bc1f160bd2bfe1de0477af0a4da69
document type
citation
dois
  1. 10.1016/S1470-2045(20)30023-1
electronic publication date
display
2020 Mar 17
precision
day
year
2020
evidence scope
bibliographic_metadata_only
id
pubmed:32192573
immutable id
pubmed:32192573@0aae694b2fd692ed9665c7526b75eab8519bc1f160bd2bfe1de0477af0a4da69
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
4
name
The Lancet. Oncology
nlm unique id
100957246
pages
541-550
volume
21
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2020 Apr;21(4):474-476. doi: 10.1016/S1470-2045(20)30086-3.
    note
    Source null
    related pmid
    32192574
    relationship
    Comment in
outcomes validated
false
pmid
32192573
provenance
batch id
4c5003fbb78890e89ae1
provider
NCBI PubMed ESummary
record sha256
b8438f6fd4075f09a07931947cb2c111843d9e4b4e38ab9f03bad658121f0fe4
response sha256
890389583ce193a9c74e19c63678e418dad2088e82cb704b888b02fcc887d269
retrieved at
2026-09-09T23:47:48.270700+00:00
publication date
display
2020 Apr
precision
month
year
2020
publication types
  1. Clinical Trial, Phase I
  2. Clinical Trial, Phase II
  3. Journal Article
  4. Multicenter Study
  5. Research Support, N.I.H., Extramural
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/32192573/
title
Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trial.

Preserved source evidence · Not medical advice